ICMR Drone Initiative Slashes TB Diagnosis Time from 15 Days to 5

The average out-of-pocket expenditure for TB diagnosis dropped from approximately 9,451 rupees under conventional methods to nearly 91 rupees through the drone-based system. File Photo.

The Indian Council of Medical Research (ICMR) has achieved a significant breakthrough in healthcare logistics by successfully utilizing drone technology to transport tuberculosis samples. Recent studies conducted in the Yadadri Bhuvanagiri district of Telangana demonstrate that drone delivery can drastically reduce diagnostic wait times. By bypassing traditional road transport, the time required to receive TB results has plummeted from fifteen days to just five days.

This initiative, integrated under the i-DRONE program, involved 840 participants to evaluate the efficacy of primary health center operations. The findings reveal that accelerated sample transport facilitates faster clinical decision making and earlier treatment commencement. This rapid confirmation is essential for disease management, as it prevents the complications often associated with diagnostic delays in remote areas.

Beyond speed, the study highlights a profound economic advantage for patients. The average out-of-pocket expenditure for TB diagnosis dropped from approximately 9,451 rupees under conventional methods to nearly 91 rupees through the drone-based system. This reduction is primarily attributed to lower travel costs and the mitigation of lost wages for patients who previously had to make multiple trips to diagnostic centers.

Dr. Rajiv Bahl, Director General of ICMR, noted that affordable and timely diagnosis remains central to national TB eradication efforts. The drone network effectively overcomes severe geographical barriers, ensuring equitable access to critical medical services for those living in isolated or difficult terrains.

Operational insights from the study indicate that while the program is highly effective, it requires careful planning regarding weather conditions and payload limitations. Continued implementation across diverse regions will generate the additional empirical evidence needed to scale this life saving technology nationwide, ultimately strengthening the resilience of public healthcare infrastructure.